Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 08.06.2026 2 Am J Clin Nutr 1 Am J Epidemiol 1 BMC Ophthalmol 1 Br J Ophthalmol 3 Diabet Med 1 Diabetes 4 Diabetes Care 26 Diabetes Obes Metab 4 Diabetologia 1 Eur J Endocrinol 1 J Am Coll Cardiol 1 J Am Soc Nephrol 1 J Clin Endocrinol Metab 2 J Diabetes Complications 5 N Engl J Med 1 Nutr Metab (Lond) 1 Ophthalmology 1 PLoS Comput Biol 1 PLoS Med 8 PLoS One 1 Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Nutr

1. YU H, Zhang J, Qian F, Liu J, et al
   Plasma proteomics enhances heart failure risk prediction among individuals with type 2 diabetes: a prospective cohort study.
   Am J Clin Nutr. 2026;123:101216.
   PubMed         Abstract available
   
   
2. YAO P
   Beyond natriuretic peptides: proteomic risk prediction for heart failure in the setting of type 2 diabetes and the price of transportability.
   Am J Clin Nutr. 2026;123:101296.
   PubMed        
   
   

   
   Am J Epidemiol

3. UELAND SIMONE D, Til B, Wenting L, Ong Henry H, et al
   Leveraging Electronic Health Record Data to Evidence Collider Stratification Bias and Inform Clinical Epidemiology: Obesity, Diabetes and Rotator Cuff Tears.
   Am J Epidemiol. 2026 Jun 1:kwag117. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

4. BOLAT S, Sonmez OA, Topuz HN, Ozbas M, et al
   Early retinal, optic disc and choriocapillaris microvascular alterations in children with type 1 diabetes without clinical retinopathy: an OCTA-based case-control study.
   BMC Ophthalmol. 2026;26:311.
   PubMed         Abstract available
   
   

   
   Br J Ophthalmol

5. KHALID H, Tsai WS, Lamanna F, Riotto E, et al
   Quantification of retinal non-perfusion in eyes with diabetic retinopathy to study the association with retinal neovascularisation: INSPIRED study report 3.
   Br J Ophthalmol. 2026 Jun 4:bjo-2025-329361. doi: 10.1136/bjo-2025-329361.
   PubMed         Abstract available
   
   

   
   Diabet Med

6. HORSSELENBERG M, Prins JB, Boenink M, Aanstoot HJ, et al
   Clustering of technological attitudes and reasons for device (non-)uptake among Dutch people with type 1 diabetes, family members and health professionals.
   Diabet Med. 2026 Jun 3:e70375. doi: 10.1111/dme.70375.
   PubMed         Abstract available
   
   
7. VAN GASTEL A, Graner-Baars M, Stiggelbout AM, Tran VT, et al
   Treatment burden and health-related quality of life in young adults with type 1 diabetes.
   Diabet Med. 2026 Jun 3:e70376. doi: 10.1111/dme.70376.
   PubMed         Abstract available
   
   
8. ZHANG J, Cao X, Yu X, Jiang M, et al
   Application of construction and validation of logistic regression model in risk prediction of non-proliferative diabetic retinopathy in type 2 diabetes mellitus.
   Diabet Med. 2026 May 29:e70374. doi: 10.1111/dme.70374.
   PubMed         Abstract available
   
   

   
   Diabetes

9. CHAN CK, Yang WS, Lin YH, Wu VC, et al
   Erratum. Unilateral Primary Aldosteronism Lacking KCNJ5 Somatic Mutations Is Associated With an Elevated Risk of New-Onset Diabetes. Diabetes 2025;74:850-859.
   Diabetes. 2026 Jun 1:db26er08a. doi: 10.2337.
   PubMed         Abstract available
   
   

   
   Diabetes Care

10. NARASAKI Y, Kalantar-Zadeh K, Zisman-Ilani Y, Klonoff DC, et al
    Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes.
    Diabetes Care. 2026 Jun 1:dc260004. doi: 10.2337/dc26-0004.
    PubMed         Abstract available
    
    
11. CHORNIY A, Owen AL, Kang RH, Cherupally M, et al
    Progression to Diabetes by Adults With Prediabetes Who Use the National Diabetes Prevention Program: A Natural Experiment.
    Diabetes Care. 2026 Jun 2:dc252485. doi: 10.2337/dc25-2485.
    PubMed         Abstract available
    
    
12. PETRELLI A, Thomas NJ, Hope SV, Bucciarelli L, et al
    Pathophysiology and Treatment of Type 1 Diabetes in Older Adults.
    Diabetes Care. 2026 Jun 4:dci250143. doi: 10.2337/dci25-0143.
    PubMed         Abstract available
    
    
13. MILLER RG, Costacou T, El Khoudary SR, Orchard TJ, et al
    Clinical Risk Factors Differ by Sex for Kidney Complications But Not Retinopathy in Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Cohort.
    Diabetes Care. 2026 Jun 4:dc260374. doi: 10.2337/dc26-0374.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

14. LJUNGBERG C, Bonnesen K, Schmidt M, Vandenbroucke-Grauls C, et al
    Empagliflozin Versus Dapagliflozin and Urogenital Adverse Events in Type 2 Diabetes: A Target Trial Emulation.
    Diabetes Obes Metab. 2026 Jun 3. doi: 10.1111/dom.70937.
    PubMed         Abstract available
    
    
15. CHEN HY, Falconer T, Ostropolets A, Anand TV, et al
    Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network Study.
    Diabetes Obes Metab. 2026 Jun 3. doi: 10.1111/dom.70918.
    PubMed         Abstract available
    
    
16. ALTERMAN N, Toledano Y, Fallach N, Gross V, et al
    Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Population-Based Study.
    Diabetes Obes Metab. 2026 Jun 3. doi: 10.1111/dom.70906.
    PubMed         Abstract available
    
    
17. LI AQY, Yarnoff B, Tam CHT, Chan JCN, et al
    Cost-Effectiveness of NT-proBNP-Guided Cardiovascular Screening in Chinese Adults With Type 2 Diabetes: Real-World Evidence From the Hong Kong Diabetes Biobank.
    Diabetes Obes Metab. 2026 Jun 3. doi: 10.1111/dom.70924.
    PubMed         Abstract available
    
    
18. SAWANT PM, Ghongade RB
    Diabetes Management Through Glucose Dynamics Analysis Network: A Novel Approach for Accurate Blood Glucose Level Forecasting.
    Diabetes Obes Metab. 2026 Jun 3. doi: 10.1111/dom.70930.
    PubMed         Abstract available
    
    
19. DINSDALE MM, Young KG, Cardoso P, Gudemann LM, et al
    Trends in Second-Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population-Based Study, 2019-2024.
    Diabetes Obes Metab. 2026 Jun 4. doi: 10.1111/dom.70960.
    PubMed         Abstract available
    
    
20. MILIA A, Silverii GA, Cortoni L, Monami M, et al
    Acupuncture May Reduce Insulin Doses in Overweight Insulin-Treated Patients With Type 2 Diabetes Mellitus: A Crossover Randomized Controlled Pilot Trial.
    Diabetes Obes Metab. 2026 Jun 3. doi: 10.1111/dom.70941.
    PubMed        
    
    
21. HEISE T, Zijlstra E, Mari A, Roell WC, et al
    Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial.
    Diabetes Obes Metab. 2026 Jun 2. doi: 10.1111/dom.70863.
    PubMed         Abstract available
    
    
22. ARSENYADIS F, Henson J, Choudhary P, Davies MJ, et al
    Greater Glycaemic Responses to Bodyweight Change in South Asians Than White Europeans at High Risk of Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Jun 1. doi: 10.1111/dom.70945.
    PubMed         Abstract available
    
    
23. KHAN MS, Valabhji J, Sattar N, Murphy H, et al
    Glycaemic Control by Sociodemographic Factors in Adults With Type 1 Diabetes in England: Trends From 2007-2008 to 2023-2024.
    Diabetes Obes Metab. 2026 Jun 1. doi: 10.1111/dom.70929.
    PubMed         Abstract available
    
    
24. AMARAL R, Costa B, Penedones A, Mendes D, et al
    Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical Trials.
    Diabetes Obes Metab. 2026 Jun 1. doi: 10.1111/dom.70905.
    PubMed         Abstract available
    
    
25. LIAO J, Huang Y, Yue R
    Cardiorenal Safety and Efficacy of Sotagliflozin: A Stratified Meta-Analysis by Diabetes Type and Dosage.
    Diabetes Obes Metab. 2026 Jun 1. doi: 10.1111/dom.70876.
    PubMed         Abstract available
    
    
26. SIMPSON FR, Espeland MA, Bertoni AG, Legins JJ, et al
    Identification of Frailty Subtypes in African American Adults With and Without Type 2 Diabetes: A Latent Class Analysis From the Jackson Heart Study.
    Diabetes Obes Metab. 2026 Jun 1. doi: 10.1111/dom.70898.
    PubMed         Abstract available
    
    
27. D'ALESSIO DA, Campbell JE
    The Duodenal Mucosa Plays a Key Role in Metabolic Regulation: Emerging Physiology and New Opportunities for Cell-Directed and Barrier-Related Interventions for the Treatment of Diabetes and Obesity.
    Diabetes Obes Metab. 2026;28 Suppl 3:3-15.
    PubMed         Abstract available
    
    
28. PALLIN JA, Holman N, McIntyre K, Smith D, et al
    Trends in Potentially Avoidable Hospitalisations Among People With Diabetes in Ireland; 2015-2024.
    Diabetes Obes Metab. 2026 May 31. doi: 10.1111/dom.70925.
    PubMed         Abstract available
    
    
29. MATSUI M, Nishimoto M, Kosugi T, Kitamura S, et al
    Adding Finerenone to SGLT2 Inhibitors and Long-Term Kidney Outcomes in Diabetic Kidney Disease.
    Diabetes Obes Metab. 2026 May 31. doi: 10.1111/dom.70934.
    PubMed         Abstract available
    
    
30. CHUANG SM, Liu SC, Chien KL, Lin CJ, et al
    The Impact of GLP-1-Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta-Analysis.
    Diabetes Obes Metab. 2026 May 31. doi: 10.1111/dom.70915.
    PubMed         Abstract available
    
    
31. ELENJICKAL EJ, Baroz F, Boileau P, Tsoukas MA, et al
    The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk.
    Diabetes Obes Metab. 2026 May 31. doi: 10.1111/dom.70886.
    PubMed         Abstract available
    
    
32. AMBIKA GOPALAKRISHNAN U, Joshi AS, Giri R, Shah SJ, et al
    Semaglutide Injection in Indian Patients With Type 2 Diabetes Mellitus: A Randomised, Phase III, Active-Controlled Study.
    Diabetes Obes Metab. 2026 May 31. doi: 10.1111/dom.70891.
    PubMed         Abstract available
    
    
33. JIN P, Ji L, Huang Y, Ding H, et al
    Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double-Blind Phase II Trial.
    Diabetes Obes Metab. 2026 May 31. doi: 10.1111/dom.70849.
    PubMed         Abstract available
    
    
34. KOTECHA P, Lee YA, Presti MF, Guo Y, et al
    Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients With Obesity and Without Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Jun 4. doi: 10.1111/dom.70904.
    PubMed        
    
    
35. YIN Y, Gao X, Li Q, Lu L, et al
    Molecular Signature of Prediabetes With High-Risk of Diabetes Revealed by Deep Plasma Proteome.
    Diabetes Obes Metab. 2026 Jun 4. doi: 10.1111/dom.70962.
    PubMed         Abstract available
    
    
36. LIU Z, Ni J, Huo R, Li X, et al
    Projecting the Macroeconomic Burden of Type 2 Diabetes Mellitus Attributable to High Body-Mass Index in Southeast Asia: A Bayesian Productivity-Adjusted Life Years Approach Based on Global Burden of Diseases 2023.
    Diabetes Obes Metab. 2026 Jun 4. doi: 10.1111/dom.70959.
    PubMed         Abstract available
    
    
37. LIM RP, Qassin S, McKenna L, Hornsey E, et al
    Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.
    Diabetes Obes Metab. 2026 Jun 4. doi: 10.1111/dom.70950.
    PubMed         Abstract available
    
    
38. GONZALEZ-VIDAL T, Rojo-Martinez G, Valdes S, Garcia-Escobar E, et al
    Association of Post-Oral Glucose Tolerance Test Hypoglycaemia With Clinical Features, Incident Diabetes and Mortality in the Di@bet.es Cohort.
    Diabetes Obes Metab. 2026 Jun 4. doi: 10.1111/dom.70951.
    PubMed         Abstract available
    
    
39. HATTORI T, Hamaguchi M, Hashimoto Y, Kitagawa N, et al
    Associations of Fasting Glucagon and the Glucagon-Alanine Index With Hepatic Steatosis and Liver Stiffness in Japanese Individuals With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Jun 5. doi: 10.1111/dom.70854.
    PubMed         Abstract available
    
    

    
    Diabetologia

40. ZHANG X, Yang A, Wu H, Lau ESH, et al
    Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetes.
    Diabetologia. 2026 Jun 5. doi: 10.1007/s00125-026-06758.
    PubMed         Abstract available
    
    
41. HU R, Hamilton N, Wang Y, Tong X, et al
    Diabetes-associated MYT1 and ST18 genes regulate human beta cell insulin secretion and survival via other diabetes risk genes.
    Diabetologia. 2026 Jun 5. doi: 10.1007/s00125-026-06757.
    PubMed         Abstract available
    
    
42. BULK J, Casanueva Reimon L, Steculorum SM
    Olfactory dysfunction in obesity and type 2 diabetes: mechanistic insights from preclinical models.
    Diabetologia. 2026 May 30. doi: 10.1007/s00125-026-06755.
    PubMed         Abstract available
    
    
43. FLINT KL, Fahey A, Longo R, Fan W, et al
    Time delays between fingerstick glucose measurements and correctional insulin administration in the hospital: do they really matter?
    Diabetologia. 2026;69:1849-1857.
    PubMed         Abstract available
    
    

    
    Eur J Endocrinol

44. PARK MJ, Hong AR, Ahn SH, Lee JH, et al
    Clinical characteristics and cardiometabolic association of non-suppressed cortisol after dexamethasone suppression test in patients with pheochromocytoma.
    Eur J Endocrinol. 2026;194:769-777.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

45. TUTTLE KR, Bakris GL, Baeres FMM, Bang CN, et al
    Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup Analyses.
    J Am Coll Cardiol. 2026;87:2996-3012.
    PubMed         Abstract available
    
    

    
    J Am Soc Nephrol

46. DENG P, Zhou H, Yu J, Li Y, et al
    Mesangial Cell-Derived Extracellular Matrix Protein 1 Is Essential for Maintaining Mesangial Matrix Homeostasis and Glomerular Architecture.
    J Am Soc Nephrol. 2026;37:1206-1220.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

47. HABTEWOLD TD, Biedrzycki RJ, Wijesiriwardhana P, Asefa NG, et al
    Association of prenatal glycemic marker cumulative exposure with placental DNA methylation change.
    J Clin Endocrinol Metab. 2026 Jan 8:dgag006. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

48. KIKUCHI Y, Hara A, Ando T, Urushihara H, et al
    Clinical inertia in patients with type 2 diabetes: A retrospective cohort study using an electronic healthcare database in Japan.
    J Diabetes Complications. 2026;40:109347.
    PubMed         Abstract available
    
    
49. HASHIMOTO Y, Yamamoto S, Takahashi F, Murai M, et al
    Impact of the AWGS2025 criteria on sarcopenia prevalence and microvascular complications in individuals with type 2 diabetes in Japan: a cross-sectional study.
    J Diabetes Complications. 2026;40:109349.
    PubMed         Abstract available
    
    

    
    N Engl J Med

50. HEERSPINK HJL, Neuen BL, Agarwal R, Cherney DZI, et al
    Finerenone in Persons with Chronic Kidney Disease without Diabetes.
    N Engl J Med. 2026 Jun 4. doi: 10.1056/NEJMoa2604625.
    PubMed         Abstract available
    
    
51. HEERSPINK HJL, McGill J, Lawatscheck R
    Finerenone in Type 1 Diabetes and Chronic Kidney Disease. Reply.
    N Engl J Med. 2026;394:2171-2172.
    PubMed        
    
    
52. GRANATA A, Corrao S
    Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
    N Engl J Med. 2026;394:2171.
    PubMed        
    
    
53. GONZALEZ FM
    Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
    N Engl J Med. 2026;394:2170-2171.
    PubMed        
    
    
54. SHAMIM MA, Varthya SB, Singh S
    Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
    N Engl J Med. 2026;394:2170.
    PubMed        
    
    

    
    Nutr Metab (Lond)

55. EBAID H, Bashandy SAE, Abdel-Mageed AM, Al-Tamimi J, et al
    Retraction Note: Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress.
    Nutr Metab (Lond). 2026;23:66.
    PubMed        
    
    

    
    Ophthalmology

56. CAI CX, Toy B, Martin B, Fan R, et al
    Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study.
    Ophthalmology. 2026 Jun 1:S0161-6420(26)00382.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

57. HESS JM, Dzeng RK, Ilies I, Schapiro D, et al
    MIAAIM: Multi-omics image integration with dimensional reduction for tissue state mapping.
    PLoS Comput Biol. 2026;22:e1014274.
    PubMed         Abstract available
    
    

    
    PLoS Med

58. LI H, Zhu Z, Yang S, Cheng W, et al
    Proteomic signatures of early retinal neurodegeneration in type 2 diabetes mellitus.
    PLoS Med. 2026;23:e1004868.
    PubMed         Abstract available
    
    

    
    PLoS One

59. ZHANG L, Wang S, Lei J, Zeng L, et al
    Immunomodulatory effects of a multi-component pharmacological intervention on diabetic peripheral neuropathy in type 2 diabetic rats: An exploratory study.
    PLoS One. 2026;21:e0350984.
    PubMed         Abstract available
    
    
60. SHAHZADI M, Younis T, Al-Qaaneh AM, Ishaq AR, et al
    Protective effects of Fraxinus xanthoxyloides bark in alloxan-induced diabetic rats: A phytochemical and pharmacological approach.
    PLoS One. 2026;21:e0346328.
    PubMed         Abstract available
    
    
61. MARTIN-BAEZ MY, Diaz-Gonzalez CM
    Preschool and primary school teachers' attitudes toward students with type 1 diabetes: A cross-sectional study.
    PLoS One. 2026;21:e0350813.
    PubMed         Abstract available
    
    
62. OSUNA M, Ruvalcaba L, Crimmins E, Cano C, et al
    Differences in life expectancy with and without disease using reported, measured, and combined estimates for hypertension and diabetes among older adults in Colombia.
    PLoS One. 2026;21:e0349777.
    PubMed         Abstract available
    
    
63. ZGHEBI SS, Cotterill S, Marsden A, Paterson L, et al
    Examining the uptake, retention, and effectiveness of a national online type 2 diabetes self-management intervention in England (Healthy Living): A retrospective cohort study.
    PLoS One. 2026;21:e0348266.
    PubMed         Abstract available
    
    
64. LIANG H, Yang T, Lu F, Lin L, et al
    Transcriptome sequencing combined with experimental verification to explore potential key genes related to uric acid in diabetic retinopathy.
    PLoS One. 2026;21:e0350132.
    PubMed         Abstract available
    
    
65. RAZA GS, Jokelainen J, Stenback V, Sodum N, et al
    Physical activity and glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1) plasma levels in different age cohorts.
    PLoS One. 2026;21:e0349883.
    PubMed         Abstract available
    
    
66. IOANNOU N, Papachristou Nadal I
    A qualitative study of midlife women with type 2 diabetes in the UK: Exploring the impact of diabetes on their well-being.
    PLoS One. 2026;21:e0350089.
    PubMed         Abstract available
    
    

    
    Retina

67. KIM SJ, Gangaputra S, Choi L, McNeer E, et al
    Inflammatory Mediators in Diabetic Macular Edema: A Prospective, Controlled Study.
    Retina. 2026 Jun 5. doi: 10.1097/IAE.0000000000004893.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum